vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and TRICO BANCSHARES (TCBK). Click either name above to swap in a different company.
TRICO BANCSHARES is the larger business by last-quarter revenue ($109.4M vs $75.5M, roughly 1.4× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 9.0%). TRICO BANCSHARES produced more free cash flow last quarter ($127.9M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 5.4%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Trico Bancshares is a U.S.-headquartered regional bank holding company operating Tri Counties Bank. It offers a full range of retail and commercial banking services including deposit products, mortgages, small business loans, and wealth management, primarily serving consumers and SMEs in Northern California.
PBYI vs TCBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $109.4M |
| Net Profit | — | $33.6M |
| Gross Margin | 69.3% | — |
| Operating Margin | 22.7% | 42.6% |
| Net Margin | — | 251.6% |
| Revenue YoY | 27.7% | 9.0% |
| Net Profit YoY | — | 15.8% |
| EPS (diluted) | $0.26 | $1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $109.4M | ||
| Q3 25 | $54.5M | $107.6M | ||
| Q2 25 | $52.4M | $103.6M | ||
| Q1 25 | $46.0M | $98.6M | ||
| Q4 24 | $59.1M | $100.4M | ||
| Q3 24 | $80.5M | $99.1M | ||
| Q2 24 | $47.1M | $97.9M | ||
| Q1 24 | $43.8M | $98.5M |
| Q4 25 | — | $33.6M | ||
| Q3 25 | $8.8M | $34.0M | ||
| Q2 25 | $5.9M | $27.5M | ||
| Q1 25 | $3.0M | $26.4M | ||
| Q4 24 | — | $29.0M | ||
| Q3 24 | $20.3M | $29.1M | ||
| Q2 24 | $-4.5M | $29.0M | ||
| Q1 24 | $-4.8M | $27.7M |
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
| Q4 25 | 22.7% | 42.6% | ||
| Q3 25 | 17.6% | 43.2% | ||
| Q2 25 | 12.7% | 36.5% | ||
| Q1 25 | 8.7% | 35.8% | ||
| Q4 24 | 22.6% | 38.7% | ||
| Q3 24 | 27.4% | 39.8% | ||
| Q2 24 | -4.6% | 40.0% | ||
| Q1 24 | -5.3% | 38.3% |
| Q4 25 | — | 251.6% | ||
| Q3 25 | 16.2% | 31.6% | ||
| Q2 25 | 11.2% | 26.6% | ||
| Q1 25 | 6.5% | 26.7% | ||
| Q4 24 | — | 221.4% | ||
| Q3 24 | 25.2% | 29.3% | ||
| Q2 24 | -9.6% | 29.7% | ||
| Q1 24 | -11.0% | 28.2% |
| Q4 25 | $0.26 | $1.02 | ||
| Q3 25 | $0.17 | $1.04 | ||
| Q2 25 | $0.12 | $0.84 | ||
| Q1 25 | $0.06 | $0.80 | ||
| Q4 24 | $0.40 | $0.88 | ||
| Q3 24 | $0.41 | $0.88 | ||
| Q2 24 | $-0.09 | $0.87 | ||
| Q1 24 | $-0.10 | $0.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $157.0M |
| Total DebtLower is stronger | $22.7M | — |
| Stockholders' EquityBook value | $130.3M | $1.3B |
| Total Assets | $216.3M | $9.8B |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $157.0M | ||
| Q3 25 | $94.4M | $298.8M | ||
| Q2 25 | $96.0M | $314.3M | ||
| Q1 25 | $93.2M | $308.3M | ||
| Q4 24 | $101.0M | $145.0M | ||
| Q3 24 | $96.7M | $320.1M | ||
| Q2 24 | $96.8M | $206.6M | ||
| Q1 24 | $107.2M | $82.8M |
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
| Q4 25 | $130.3M | $1.3B | ||
| Q3 25 | $115.3M | $1.3B | ||
| Q2 25 | $104.7M | $1.3B | ||
| Q1 25 | $97.1M | $1.3B | ||
| Q4 24 | $92.1M | $1.2B | ||
| Q3 24 | $71.1M | $1.2B | ||
| Q2 24 | $48.5M | $1.2B | ||
| Q1 24 | $51.0M | $1.2B |
| Q4 25 | $216.3M | $9.8B | ||
| Q3 25 | $202.9M | $9.9B | ||
| Q2 25 | $194.9M | $9.9B | ||
| Q1 25 | $196.2M | $9.8B | ||
| Q4 24 | $213.3M | $9.7B | ||
| Q3 24 | $220.7M | $9.8B | ||
| Q2 24 | $205.0M | $9.7B | ||
| Q1 24 | $214.1M | $9.8B |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $133.3M |
| Free Cash FlowOCF − Capex | $14.4M | $127.9M |
| FCF MarginFCF / Revenue | 19.1% | 116.9% |
| Capex IntensityCapex / Revenue | 0.0% | 4.9% |
| Cash ConversionOCF / Net Profit | — | 3.96× |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | $222.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $133.3M | ||
| Q3 25 | $9.7M | $45.1M | ||
| Q2 25 | $14.1M | $29.2M | ||
| Q1 25 | $3.6M | $24.5M | ||
| Q4 24 | $15.6M | $109.7M | ||
| Q3 24 | $11.0M | $28.6M | ||
| Q2 24 | $1.0M | $31.8M | ||
| Q1 24 | $11.2M | $25.1M |
| Q4 25 | $14.4M | $127.9M | ||
| Q3 25 | $9.7M | $43.2M | ||
| Q2 25 | $14.1M | $28.2M | ||
| Q1 25 | $3.6M | $22.8M | ||
| Q4 24 | $15.6M | $105.2M | ||
| Q3 24 | $11.0M | $27.3M | ||
| Q2 24 | $1.0M | $30.8M | ||
| Q1 24 | — | $24.1M |
| Q4 25 | 19.1% | 116.9% | ||
| Q3 25 | 17.7% | 40.2% | ||
| Q2 25 | 26.8% | 27.2% | ||
| Q1 25 | 7.7% | 23.1% | ||
| Q4 24 | 26.4% | 104.8% | ||
| Q3 24 | 13.7% | 27.6% | ||
| Q2 24 | 2.1% | 31.5% | ||
| Q1 24 | — | 24.4% |
| Q4 25 | 0.0% | 4.9% | ||
| Q3 25 | 0.0% | 1.7% | ||
| Q2 25 | 0.0% | 1.0% | ||
| Q1 25 | 0.1% | 1.7% | ||
| Q4 24 | 0.0% | 4.5% | ||
| Q3 24 | 0.0% | 1.3% | ||
| Q2 24 | 0.0% | 1.0% | ||
| Q1 24 | 0.0% | 1.0% |
| Q4 25 | — | 3.96× | ||
| Q3 25 | 1.10× | 1.33× | ||
| Q2 25 | 2.41× | 1.06× | ||
| Q1 25 | 1.21× | 0.93× | ||
| Q4 24 | — | 3.78× | ||
| Q3 24 | 0.54× | 0.98× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
